BVMF/H1CA34 (BVMF/H1CA34)

Brazil Stock Exchange: BVMF/H1CA34 · BRL

R$120

-5.09 (-4.1%)· Recorded snapshot

Market cap	520.9B
Revenue (ttm)	407.7B
Net income (ttm)	35.1B
EPS (ttm)	R$8.09
P/E (trailing)	14.9x
P/E (forward)	15.1x
Dividend	R$0.54 (0.45%)
Volume	45
Beta	1.11

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 407.7B
Net income (ttm): 35.1B
EPS (ttm): R$8.09
P/E (trailing): 14.9x
P/E (forward): 15.1x
Market cap: 520.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E15.1

P25 n/aP50 n/aP75 n/a

Trailing P/E14.9

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC21.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/H1CA34 indicators

Market & fundamental data

Available fields

241

Groups with data

Currency

USD

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-27
Employees	320,000
Employees change	4,000
Employees growth	1.27%
Enterprise value	BRL 815B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1968
Industry	Medical Care Facilities
Is primary listing	No
ISIN number	BRH1CABDR002
Last earnings date	2026-10-27
Last refreshed	2026-10-28
Last stock split date	2022-11-28
Last stock split type	Forward
Market cap	BRL 520.9B
Next earnings date	2027-01-22
Price	BRL 120.36
Price currency	BRL
Sector	Healthcare
SIC code	8062
Stock price date	2026-10-27
Symbol	bvmf/H1CA34
Website	https://www.hcahealthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	12.9x
Average P/E ratio (3Y)	14.91x
Average P/E ratio (5Y)	13.5x
Earnings yield	6.72%
EV/Earnings	23.22x
EV/EBIT	12.57x
EV/EBITDA	9.03x
EV/FCF	26.34x
EV/Sales	1.94x
FCF / EV yield	3.8%
FCF yield	5.94%
Forward P/E	15.07x
Lynch fair value	BRL 40.55
Lynch upside	-66.31%
P/(FCF - SBC) ratio	18.06x
P/(OCF - SBC) ratio	9.34x
P/E ratio	14.89x
P/FCF ratio	16.84x
P/OCF ratio	9x
P/S ratio	1.28x
Price/EBITDA ratio	6.37x
Sector forward P/E	11.27x
Sector P/E	41.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	15.31%
EBITDA margin	20.06%
Effective tax rate	20.6%
FCF margin	7.35%
Gross margin	42.76%
Operating margin	15.31%
Pretax margin	12.48%
Profit margin	8.61%
Profit per employee	BRL 127,633
Profitable quarters	66
Profitable years	18
Revenue per employee	BRL 1.5M
ROA	12.23%
ROA (5Y)	11.64%
ROCE	27.6%
ROIC	21.36%
ROIC (5Y)	19.69%
SBC / revenue	0.51%
Tax / revenue	2.57%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	17.06%
EPS growth (Q)	4.45%
EPS growth (QoQ)	-4.6%
EPS growth 10Y	16.95%
EPS growth 3Y	13.98%
EPS growth 5Y	9.12%
EPS growth quarters	6
EPS growth years	2
FCF growth	-26.22%
FCF growth (Q)	-0.77%
FCF growth (QoQ)	181.16%
FCF growth 3Y	10.93%
Gross profit growth	9.35%
Gross profit growth (Q)	5.38%
Gross profit growth 3Y	11.24%
Gross profit growth 5Y	8.44%
Net income growth	6.81%
Net income growth (Q)	-3.9%
Net income growth (QoQ)	-7.06%
Net income growth 3Y	5.83%
Net income growth 5Y	0.63%
Net income growth quarters	6
Net income growth years	2
OCF growth	-12.99%
OCF growth (Q)	1.02%
OCF growth (QoQ)	91.05%
OCF growth 10Y	7.32%
OCF growth 3Y	6.36%
OCF growth 5Y	30.66%
Operating income growth	3.6%
Operating income growth (Q)	-0.71%
Operating income growth 3Y	9.26%
Operating income growth 5Y	4.35%
Revenue growth	5.82%
Revenue growth (Q)	3.59%
Revenue growth (QoQ)	-1.88%
Revenue growth 10Y	6.71%
Revenue growth 3Y	7.61%
Revenue growth 5Y	6.3%
Revenue growth quarters	15
Revenue growth years	16

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -26.9B
Depreciation and amortization	BRL 20B
EBIT	BRL 62.4B
EBITDA	BRL 81.8B
EPS	BRL 8.09
Financing cash flow	BRL -26.8B
Free cash flow	BRL 30.9B
Free cash flow minus SBC	BRL 28.8B
Gross profit	BRL 174.3B
Income taxes	BRL 10.5B
Investing cash flow	BRL -31.5B
Net borrowing	BRL 30.9B
Net cash flow	BRL -461M
Net income	BRL 35.1B
Operating cash flow minus SBC	BRL 55.8B
Operating income	BRL 62.4B
Revenue	BRL 407.7B
Stock-based compensation	BRL 2.1B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	BRL -192.61
Debt / EBITDA	3.12
Debt / FCF	8.78
Interest coverage	5.1
Long-term assets	BRL 241.9B
Long-term liabilities	BRL 246.7B
Net cash (debt)	BRL -266.9B
Net cash / market cap	-51.23%
Net debt / EBITDA	3.26
Net debt / FCF	8.63
Piotroski F-Score	6
Property, plant and equipment	BRL 184.5B
Shareholders' equity	BRL -23.8B
Tangible book value	BRL -99.8B
Tangible book value per share	BRL -459.68
Total assets	BRL 328.7B
Total cash	BRL 4.7B
Total debt	BRL 271.6B
Total liabilities	BRL 352.5B
WACC	8.03%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.28
Current assets	BRL 86.8B
Current liabilities	BRL 105.8B
Current ratio	0.82
Inventory turnover	26.47
Net working capital	BRL 18.8B
Quick ratio	0.63
Working capital	BRL -18.4B
Working capital turnover	-132.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	8.7%
Dividend growth	0.95%
Dividend growth (3Y)	10.69%
Dividend growth (5Y)	15.84%
Dividend growth years	5
Dividend payment date	2026-10-06
Dividend payment years	7
Dividend payout frequency	Quarterly
Dividend per share	BRL 0.54
Dividend yield	0.45%
Ex-dividend date	2026-09-15
Last dividend	BRL 0.14
Payout ratio	10.05%
Shareholder yield	9.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 116.16
1D price change	-4.06%
1M price change	5.19%
1M total return	5.19%
1W price change	4.59%
1W total return	4.59%
1Y price change	-1.95%
1Y return CAGR	-1.49%
1Y total return	-1.48%
20-day SMA	BRL 113.26
200-day SMA	BRL 114.40
3M price change	23.96%
3M total return	24.11%
3Y price change	115.89%
3Y return CAGR	29.91%
3Y total return	119.27%
50-day SMA	BRL 107.03
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 143.06
52-week high date	2026-03-04
52-week low	BRL 91.80
52-week low date	2026-07-14
5Y price change	78.57%
5Y return CAGR	12.93%
5Y total return	83.67%
6M price change	10.61%
6M total return	10.9%
All-time high	BRL 143.06
All-time high date	2026-03-04
All-time low	BRL 16.30
All-time low date	2020-03-18
Average true range (ATR)	BRL 4.13
Average volume	108.9
Beta (5Y)	1.11
Change from 52-week high	-15.87%
Change from 52-week low	31.11%
Change from all-time high	-15.87%
Change from all-time low	638.4%
Change from open	-6.95%
Day's gap	3.11%
Dollar volume	BRL 5,416
High price	BRL 129.35
Low price	BRL 120.36
Monthly RSI	57.37
Open price	BRL 129.35
Position in 52-week range	0%
Previous close	BRL 125.45
Price vs 150-day SMA	3.62%
Price vs 20-day SMA	6.27%
Price vs 200-day SMA	5.21%
Price vs 50-day SMA	12.46%
Relative volume	0.41
RSI	60.23
Sharpe ratio	0.67
Sharpe ratio (3Y)	0.6
Sortino ratio	1.09
Sortino ratio (3Y)	1
Volume	45
Weekly RSI	60.49
YTD price change	-7.36%
YTD total return	-7.02%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	144.3M
Shares change (QoQ)	-2.52%
Shares change (YoY)	-8.7%
Shares held by insiders	1.43%
Shares held by institutions	62.15%
Short ratio	3.7 days

Deeper analysis on BVMF/H1CA34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/H1CA34 report

Is a complete BVMF/H1CA34 research report available?

No complete published report is available for bvmf/H1CA34 (BVMF/H1CA34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/H1CA34 (BVMF/H1CA34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/H1CA34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/H1CA34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/H1CA34

Frequently asked questions